Rosanna Pellegrini Selected Research

Castration

2/2018	A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with 223Radium-dichloride.
1/2016	Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosanna Pellegrini Research Topics

Disease

3	Neoplasm Metastasis (Metastasis) 09/2017 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 02/2018 - 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

1	RadiopharmaceuticalsIBA 01/2016
1	Radioisotopes (Radionuclides)IBA 01/2016

Therapy/Procedure

3	Therapeutics 09/2017 - 01/2016
3	Gamma Cameras (Gamma Camera) 09/2017 - 01/2006
2	Castration 02/2018 - 01/2016
1	Injections 01/2016